Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
190.00    3.00 (1.62%)
Bid:
185.00
Ask:
195.00
Spread: 10.00 (5.405%)
Market Cap: £99.47m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Update

30 Jul 2024 07:00

RNS Number : 2695Y
Somero Enterprises Inc.
30 July 2024
 

30 July 2024

Somero Enterprises, Inc.

("Somero" or "the Company")

 

Trading Update

Somero® is pleased to provide an update on trading ahead of its interim results announcement scheduled to be released on Thursday, 29 August 2024.

While the broad US non-residential construction market remains healthy, supported by an active manufacturing sector, onshoring, and electric vehicle and battery plants, trading in North America continues to be impeded by project start delays and pauses caused by elevated interest rates, labor shortages and concrete rationing, as previously reported in the 20 June 2023 announcement. This has been coupled with significant inclement weather in H1 2024. As a result, H1 2024 trading in North America is expected to end below the comparable H1 2023 period.

 

The European market was active during H1 2024, reflective of positive non-residential construction market conditions and a busy customer base with healthy project backlogs. As a result, H1 2024 trading in Europe was comparable to H1 2023. Australia also experienced inclement weather that caused project delays resulting in H1 2024 trading down compared to a record performance in H1 2023. Trading in the Rest of World region declined compared to H1 2023, driven primarily by lower sales volume in the Middle East and Latin America. As previously stated, given the relatively small base of business in each region within this category, trading will fluctuate from period to period. 

 

The Company anticipates an improvement in H2 2024 over H1 2024 driven by a combination of new product revenue growth, including the launch of a third new machine, and an expectation of improved weather conditions. Due to the anticipated reduction in 2024 revenue compared to previous expectations and consistent with Somero's agile operating model, the Company has initiated a company-wide workforce reduction of approximately 15%, a restructuring that takes effect alongside this trading update. The workforce reduction combined with a reduction in variable expenses tied to revenue and strict cost controls for the remainder of 2024 partly offset the profitability impact of the revised 2024 revenue expectations. 

 

In consideration of the aforementioned factors, the Company now expects FY 2024 revenues of approximately US$ 110.0m (compared to the previous market consensus estimate of US$ 120.7m), EBITDA of approximately US$ 30.0m (compared to the previous market consensus estimate of US$ 34.0m), and year-end cash of approximately US$ 27.0m (compared to the previous market consensus estimate of US$ 31.7m). 

 

Jack Cooney, President & CEO of Somero, said:

 

"Despite the impact of persistent challenges and poor weather conditions on trading in the first half, the non-residential construction market remains fundamentally sound. Importantly, the long-term growth drivers remain intact and we are working hard to expand our product offering and build our presence internationally to capitalize. As those factors outside our control abate, we would expect performance to improve. In the meantime, Somero is built to withstand challenging conditions. We have a solid track record of adapting to changing conditions and then emerging strongly."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this Announcement, this inside information is now considered to be in the public domain.

 

 

For further information, please contact:

 

Somero Enterprises, Inc.

www.somero.com

Jack Cooney, President & CEO

+1 239 210 6500

Vincenzo LiCausi, CFO

Howard Hohmann, EVP Sales

 

Cavendish Capital Markets Ltd (NOMAD and Broker)

+44 (0)20 7220 0500

Matt Goode/Seamus Fricker (Corporate Finance)

 

Tim Redfern/Harriet Ward (ECM)

 

 

 

Alma (Financial Communications Advisor)

somero@almastrategic.com

David Ison

+44 (0)20 3405 0205

Rebecca Sanders-Hewett

 

Will Merison

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKCBQPBKDBOB
Date   Source Headline
16th Apr 20214:35 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSTransaction in Own Shares and RSUs
15th Mar 20213:50 pmRNSTransaction in Own Shares and RSUs
11th Mar 20215:00 pmRNSHolding(s) in Company
10th Mar 20217:00 amRNSFinal Results
5th Mar 20215:00 pmRNSHolding(s) in Company
1st Mar 20212:50 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSTrading Update
15th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Nov 20207:00 amRNSTrading Statement
13th Nov 20204:22 pmRNSHolding(s) in Company
11th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Sep 20207:00 amRNSHolding(s) in Company
29th Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 20203:49 pmRNSTransactions in Own Shares
22nd Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Sep 20209:05 amRNSSecond Price Monitoring Extn
9th Sep 20209:00 amRNSPrice Monitoring Extension
9th Sep 20207:00 amRNSInterim Results
13th Aug 20205:22 pmRNSHolding(s) in Company
4th Aug 20201:53 pmRNSHolding(s) in Company
14th Jul 20207:00 amRNSTrading Update
23rd Jun 20201:54 pmRNSHolding(s) in Company
10th Jun 20207:00 amRNSResult of AGM
8th Jun 20207:00 amRNSAGM Statement
5th Jun 20207:00 amRNSCOVID-19 Update
26th May 20207:00 amRNSAnnual Report Correction - Replacement
22nd May 20205:30 pmRNSAnnual Report Correction
16th Apr 20207:00 amRNSAnnual Report, AGM Notice & QCA CG Code Adoption
30th Mar 20207:00 amRNSCOVID-19 Update
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20209:00 amRNSPrice Monitoring Extension
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSTransactions in Own Shares and RSUs
16th Mar 202011:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.